Henrike E. Karim‐Kos

4.0k total citations · 1 hit paper
67 papers, 2.7k citations indexed

About

Henrike E. Karim‐Kos is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Henrike E. Karim‐Kos has authored 67 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 18 papers in Pediatrics, Perinatology and Child Health and 18 papers in Epidemiology. Recurrent topics in Henrike E. Karim‐Kos's work include Childhood Cancer Survivors' Quality of Life (17 papers), Global Cancer Incidence and Screening (15 papers) and Acute Lymphoblastic Leukemia research (15 papers). Henrike E. Karim‐Kos is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (17 papers), Global Cancer Incidence and Screening (15 papers) and Acute Lymphoblastic Leukemia research (15 papers). Henrike E. Karim‐Kos collaborates with scholars based in Netherlands, United States and United Kingdom. Henrike E. Karim‐Kos's co-authors include J.W.W. Coebergh, Esther de Vries, Isabelle Soerjomataram, V.E.P.P. Lemmens, Sabine Siesling, Lambertus A. Kiemeney, Otto Visser, Melina Arnold, M.L.G. Janssen‐Heijnen and David Forman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Henrike E. Karim‐Kos

63 papers receiving 2.7k citations

Hit Papers

Recent trends of cancer in Europe: A combined approach of... 2008 2026 2014 2020 2008 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s
    2008 592 citations Henrike E. Karim‐Kos, Esther de Vries et al. European Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henrike E. Karim‐Kos Netherlands 27 1.4k 582 453 396 379 67 2.7k
Hassan Errihani Morocco 25 1.3k 1.0× 568 1.0× 514 1.1× 335 0.8× 375 1.0× 306 2.6k
Sercan Aksoy Türkiye 27 1.7k 1.3× 780 1.3× 428 0.9× 350 0.9× 334 0.9× 284 3.6k
Rajaraman Swaminathan India 30 1.6k 1.2× 468 0.8× 640 1.4× 935 2.4× 308 0.8× 96 3.4k
Reda Wilson United States 20 985 0.7× 460 0.8× 258 0.6× 431 1.1× 153 0.4× 42 2.3k
Wakiko Ajiki Japan 29 1.2k 0.9× 877 1.5× 728 1.6× 428 1.1× 257 0.7× 66 2.7k
Patricia M. Jamison United States 13 1.4k 1.0× 505 0.9× 307 0.7× 393 1.0× 323 0.9× 19 2.5k
Ádám Gondos Germany 36 1.9k 1.4× 640 1.1× 653 1.4× 573 1.4× 629 1.7× 80 3.9k
Christopher J. Johnson United States 25 1.3k 1.0× 425 0.7× 281 0.6× 618 1.6× 229 0.6× 41 2.7k
Claudia Allemani United Kingdom 28 2.3k 1.7× 731 1.3× 486 1.1× 551 1.4× 801 2.1× 84 4.3k
Judith S. Kaur United States 28 2.0k 1.5× 550 0.9× 316 0.7× 637 1.6× 241 0.6× 115 3.8k

Countries citing papers authored by Henrike E. Karim‐Kos

Since Specialization
Citations

This map shows the geographic impact of Henrike E. Karim‐Kos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrike E. Karim‐Kos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrike E. Karim‐Kos more than expected).

Fields of papers citing papers by Henrike E. Karim‐Kos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrike E. Karim‐Kos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrike E. Karim‐Kos. The network helps show where Henrike E. Karim‐Kos may publish in the future.

Co-authorship network of co-authors of Henrike E. Karim‐Kos

This figure shows the co-authorship network connecting the top 25 collaborators of Henrike E. Karim‐Kos. A scholar is included among the top collaborators of Henrike E. Karim‐Kos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrike E. Karim‐Kos. Henrike E. Karim‐Kos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Capocaccia, Riccardo, Jasper van der Lugt, Mariëtte E.G. Kranendonk, et al.. (2025). Long-term survival and cure fraction estimates for paediatric central nervous system tumours in 31 European countries (EUROCARE-6): a population-based study. The Lancet Oncology. 26(8). 1091–1099.
3.
Schulpen, Maya, An Van Damme, Rob Pieters, et al.. (2024). Incidence, survival, and mortality of cancer in children and young adolescents in Belgium and the Netherlands in 2004–2015: A comparative population‐based study. International Journal of Cancer. 155(2). 226–239. 1 indexed citations
4.
Crespi, Catherine M., Madhuri Sudan, Jukka Juutilainen, et al.. (2024). International study of childhood leukemia in residences near electrical transformer rooms. Environmental Research. 249. 118459–118459. 2 indexed citations
5.
Duncan, Catriona, Arnauld Verschuur, Beatriz de Camargo, et al.. (2023). Impact of the COVID‐19 pandemic on paediatric renal tumour presentation and management, a SIOP renal tumour study group study. Cancer Medicine. 12(16). 17098–17111. 4 indexed citations
6.
Kwast, A.B.G., Joep P. M. Derikx, Miranda P. Dierselhuis, et al.. (2021). Opposite Incidence Trends for Differentiated and Medullary Thyroid Cancer in Young Dutch Patients over a 30-Year Time Span. Cancers. 13(20). 5104–5104. 11 indexed citations
7.
Reedijk, Ardine, Margriet van der Heiden‐van der Loo, Otto Visser, et al.. (2017). Site of childhood cancer care in the Netherlands. European Journal of Cancer. 87. 38–46. 17 indexed citations
8.
Hossain, Mohammad Sorowar, et al.. (2016). Epidemiology of childhood and adolescent cancer in Bangladesh, 2001–2014. BMC Cancer. 16(1). 104–104. 20 indexed citations
9.
Houweling, Tanja A. J., Henrike E. Karim‐Kos, Margarete C. Kulik, et al.. (2016). Socioeconomic Inequalities in Neglected Tropical Diseases: A Systematic Review. PLoS neglected tropical diseases. 10(5). e0004546–e0004546. 101 indexed citations
10.
Issa, Djamila E., S.A.M. van de Schans, Martine E.D. Chamuleau, et al.. (2014). Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010. Haematologica. 100(4). 525–533. 37 indexed citations
11.
Arnold, Melina, Maarten A. Wildeman, Otto Visser, et al.. (2012). Lower mortality from nasopharyngeal cancer in The Netherlands since 1970 with differential incidence trends in histopathology. Oral Oncology. 49(3). 237–243. 32 indexed citations
12.
Witjes, Caroline D.M., Henrike E. Karim‐Kos, Otto Visser, et al.. (2012). Hepatocellular carcinoma in a low-endemic area. European Journal of Gastroenterology & Hepatology. 24(4). 1–1. 21 indexed citations
13.
Witjes, Caroline D.M., Otto Visser, Henrike E. Karim‐Kos, et al.. (2012). Gallbladder Cancer in the Netherlands: Incidence, Treatment and Survival Patterns since 1989. Digestive Surgery. 29(2). 92–98. 26 indexed citations
14.
Altena, Anne M. van, Henrike E. Karim‐Kos, Esther de Vries, et al.. (2012). Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands. Gynecologic Oncology. 125(3). 649–654. 41 indexed citations
15.
Siesling, Sabine, Otto Visser, Henrike E. Karim‐Kos, et al.. (2011). Volwassen kankerpatiënten overleven langer in Nederland 5-jaarsoverleving 12% toegenomen tussen 1989-1993 en 2004-2008. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 2011(155). 1–8. 2 indexed citations
16.
Siesling, Sabine, Otto Visser, Henrike E. Karim‐Kos, et al.. (2011). Adult cancer patients survive longer in the Netherlands: 5-Year survival rate increased by 12% between 1989-1993 and 2004-2008. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 155(12). 514–521. 1 indexed citations
17.
Drift, Miep A. van der, Henrike E. Karim‐Kos, Sabine Siesling, et al.. (2011). Progress in Standard of Care Therapy and Modest Survival Benefits in the Treatment of Non-small Cell Lung Cancer Patients in the Netherlands in the Last 20 Years. Journal of Thoracic Oncology. 7(2). 291–298. 49 indexed citations
18.
19.
Kok, Inge M.C.M. de, Maaike A. van der Aa, Marjolein van Ballegooijen, et al.. (2010). Trends in cervical cancer in the Netherlands until 2007: Has the bottom been reached?. International Journal of Cancer. 128(9). 2174–2181. 45 indexed citations
20.
Steenbergen, Liza N. van, Pieta Krijnen, V.E.P.P. Lemmens, et al.. (2010). Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989–2006. Annals of Oncology. 21(11). 2206–2212. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hassan Errihani Breakdown of academic impact, for papers by Sercan Aksoy Breakdown of academic impact, for papers by Rajaraman Swaminathan Breakdown of academic impact, for papers by Reda Wilson Breakdown of academic impact, for papers by Wakiko Ajiki Breakdown of academic impact, for papers by Patricia M. Jamison Breakdown of academic impact, for papers by Ádám Gondos Breakdown of academic impact, for papers by Christopher J. Johnson Breakdown of academic impact, for papers by Claudia Allemani Breakdown of academic impact, for papers by Judith S. Kaur
Rankless by CCL
2026